Overview

Gender

male

David Granville, Ph.D. Co-founder and Scientific Founder of the Company in 2008, David Granville serves as the Company’s Chief Scientific Officer (CSO) and is a Full Professor and Director of the GEM Facility at the Providence Heart + Lung Institute at St. Paul’s Hospital, University of British Columbia (UBC).

David Granville completed his Ph.D. at UBC and post-doctoral training at the Scripps Research Institute (La Jolla, CA). He worked in preclinical pharmacology at QLT Inc. from 1994-2000.

David Granville was recruited to UBC in 2003 as a Tier II Canada Research Chair and Michael Smith Foundation for Health Research Scholar. Since then, David Granville has received numerous awards for his scholarly and research achievements including a Canada Top 40 Under 40™ award, 2010 Business in Vancouver Forty Under 40 award, 2006 UBC Outstanding Young Alumnus Award, 2007 Simon Fraser University Academic Alumnus Award, 2008 Canadian Academy of Pathology Scientist award and was a finalist for the prestigious 2007 Louis and Arnold Katz Basic Science Prize at the American Heart Association Scientific Sessions.